Mobile Phone Use and Travel Behaviour of Adult Residents of Ile-Ife, Southwestern Nigeria

This study examined the influence of mobile phone use on the frequency of trips which Ile-Ife residents made on social activities. The study covered eleven electoral wards of the urban Ile-Ife. Purposive sampling method was used to select a sample size of 330 working adults who were mobile phones users and between aged 35 years and 50 years. Moreover, to obtain the qualitative data, purposive sampling method was adopted to obtain a total sample size of 22 for in-depth interviews. Contents analysis and descriptive statistics were used to analyze the qualitative data and the quantitative data respectively. This study found an increase in frequency of trips made on visitation to friend and relatives, business/work, religion purposes while mobile phone use did not influence the frequency of trips made on recreational purposes and ceremonies. This study concluded that mobile phone use influenced the frequency of some trips which the adults in Ile-Ife, Southwestern Nigeria made on social activities. Keywords: mobile phone, travel behaviour, social activities

Acute administration of co-artesiane induces oxidative stress in the testes of adult male Wistar rats

Co-artesiane is an artemether-lumefantrine combination therapy that is used in the treatment of malaria. In this work we studied the toxicological effect of this drug with reference to seminal and biochemical parameters of the male reproductive system of wistar rats. Twenty (20) adult male rats were divided into four groups of five rats per group. Group A was administered a single dose (4 mg/kg/bw) of Co-artesiane, Group B was administered double dose (8 mg/kg/bw) of Co-artesiane and Group C received 10 mg/kg/bw of the drug for a period of 3 days. Group D served as control and received physiologic saline. In each group body weight, testicular weight, sperm count, motility and viability as well as oxidative stress status were assessed by evaluating the activities of reduced glutathione, Glutathione S-transferase, catalase, super oxide dismutase (SOD) and malondialdehyde (MDA). The mean sperm count, motility and viability in rats treated with Co-artesiane were reduced when compared with controls. Biochemical analyses showed increase in the activities of oxidative stress markers in a dose-dependent manner. The results suggest that the graded dose of Co-artesiane® elicit depletion of antioxidant defense system and induced oxidative stress in the rats

Effect of Xylopia aethiopica, Fiscus mucuso and Anthocleista vogelli extracts on some Biochemical Parameters following ethanol-Induced Toxicity.

A total of forty rats were divided into eight groups (n= 5). Group A were control rats; Group B 27 were administered with absolute ethanol; Group C were ethanol administered rats treated with 28 Xylopia aethiopica; Groups D were ethanol administered rats treated with Fiscus mucuso, Group 29 E were ethanol administered rats treated with Anthocleista vogelli; Group F were normal rats 30 administered orally with Xylopia aethiopica; Group G were normal rats administered orally with 31 Fiscus mucuso; Group H were normal rats administered orally with Anthocleista vogelli. At the 32 end of the experimental period, the animals were sacrificed and serum was obtained for total 33 protein, uric acid, creatinin, urea, Aspartate aminotrasferase (AST) and Alanine aminotransferase 34 (ALT) analysis using respective research kits. 35 The result showed that Xylopia aethiopica had protective effect on the kidney as compared with 36 Fiscus mucuso and Anthocleista vogelli treated rats. Also, The AST and ALT was lowered with 37 the start of Xylopia aethiopia treatment. The total protein, creatinin and urea were slightly 38 (p> 0.05) affected with ethanol, an effect which was normalized with the start of extract 39 treatment. 4

BIOCHEMICAL CHANGES IN STREPTOZOTOCIN-INDUCED DIABETIC RATS AFTER TREATMENT WITH ETHANOLIC LEAF EXTRACT OF Croton Zambesicus (Müll. Arg.)

Objective: This study was designed to evaluate the effect of ethanolic leaf extract of C. zambesicus on total protein (TP), albumin (ALB), globulin (GLO), lactate dehydrogenase (LDH) and glucose-6-phosphate dehydrogenase (G6PDH) in streptozotocin (STZ) induced diabetic rats. Methods: Seventy adult male wistar rats were divided into seven groups (n=10). Group A, control rats; Group B, untreated diabetic rats; Group C, diabetic rats in which C. zambesicus therapy started 2 weeks prior to induction of diabetes; Group D, diabetic rats administered orally with C. zambesicus leafextract for 2 weeks after the initial four weeks of diabetic induction; Group E, diabetic rats administered orally with C. zambesicus leaf extract for 4 weeks after the initial four weeks of diabetic induction; Group F, normal rats administered orally with C. zambesicus leaf extract for four weeks; Group G, diabetic rats administered with glimepiride (2 mg/kg/day) for four weeks after the initial four weeks of diabetic induction. At the end of the experimental period, the animals were weighed and sacrificed. Serum was obtained for TP, ALB, LDH and G6PDH analysis using respective diagnostic kits. Results: The results showed an improvement in protein metaboloites (TP, ALB, GLO) whiles the LDH and G6PDH in the extract and glimepiride treated groups were restored near normal level when compared with normal control (group A). Conclusion: In conclusion, this study showed that C. zambesicus leaf extract exerts positive effects on serum levels of TP, ALB, GLO, LDH and G6PDH in diabetic rats. Thus, ethanolic leaf extract of Croton zambesicus can be adopted in the management of diabetes mellitus

Microfluidic device utilizing magnetohydrodynamics and method for fabrication thereof

Microfluidic channels utilizing magnetohydrodynamics are used to pump very small volumes of solution. The channels have electrodes along the walls and a current carrying species within a solution carries current through the solution. The combination of the electric and magnetic fields causes the solution to flow through the channel

Prevalence and Prognostic Features of ECG Abnormalities in Acute Stroke: Findings From the SIREN Study Among Africans

Background Africa has a growing burden of stroke with associated high morbidity and a 3-year fatality rate of 84%. Cardiac disease contributes to stroke occurrence and outcomes, but the precise relationship of abnormalities as noted on a cheap and widely available test, the electrocardiogram (ECG), and acute stroke outcomes have not been previously characterized in Africans. Objectives The study assessed the prevalence and prognoses of various ECG abnormalities among African acute stroke patients encountered in a multisite, cross-national epidemiologic study. Methods We included 890 patients from Nigeria and Ghana with acute stroke who had 12-lead ECG recording within first 24 h of admission and stroke classified based on brain computed tomography scan or magnetic resonance imaging. Stroke severity at baseline was assessed using the Stroke Levity Scale (SLS), whereas 1-month outcome was assessed using the modified Rankin Scale (mRS). Results Patients\u27 mean age was 58.4 ± 13.4 years, 490 were men (55%) and 400 were women (45%), 65.5% had ischemic stroke, and 85.4% had at least 1 ECG abnormality. Women were significantly more likely to have atrial fibrillation, or left ventricular hypertrophy with or without strain pattern. Compared to ischemic stroke patients, hemorrhagic stroke patients were less likely to have atrial fibrillation (1.0% vs. 6.7%; p = 0.002), but more likely to have left ventricular hypertrophy (64.4% vs. 51.4%; p = 0.004). Odds of severe disability or death at 1 month were higher with severe stroke (AOR: 2.25; 95% confidence interval: 1.44 to 3.50), or atrial enlargement (AOR: 1.45; 95% confidence interval: 1.04 to 2.02). Conclusions About 4 in 5 acute stroke patients in this African cohort had evidence of a baseline ECG abnormality, but presence of any atrial enlargement was the only independent ECG predictor of death or disability

Novel functional insights into ischemic stroke biology provided by the first genome-wide association study of stroke in indigenous Africans

\ua9 The Author(s) 2024. Background: African ancestry populations have the highest burden of stroke worldwide, yet the genetic basis of stroke in these populations is obscure. The Stroke Investigative Research and Educational Network (SIREN) is a multicenter study involving 16 sites in West Africa. We conducted the first-ever genome-wide association study (GWAS) of stroke in indigenous Africans. Methods: Cases were consecutively recruited consenting adults (aged > 18 years) with neuroimaging-confirmed ischemic stroke. Stroke-free controls were ascertained using a locally validated Questionnaire for Verifying Stroke-Free Status. DNA genotyping with the H3Africa array was performed, and following initial quality control, GWAS datasets were imputed into the NIH Trans-Omics for Precision Medicine (TOPMed) release2 from BioData Catalyst. Furthermore, we performed fine-mapping, trans-ethnic meta-analysis, and in silico functional characterization to identify likely causal variants with a functional interpretation. Results: We observed genome-wide significant (P-value < 5.0E−8) SNPs associations near AADACL2 and miRNA (MIR5186) genes in chromosome 3 after adjusting for hypertension, diabetes, dyslipidemia, and cardiac status in the base model as covariates. SNPs near the miRNA (MIR4458) gene in chromosome 5 were also associated with stroke (P-value < 1.0E−6). The putative genes near AADACL2, MIR5186, and MIR4458 genes were protective and novel. SNPs associations with stroke in chromosome 2 were more than 77 kb from the closest gene LINC01854 and SNPs in chromosome 7 were more than 116 kb to the closest gene LINC01446 (P-value < 1.0E−6). In addition, we observed SNPs in genes STXBP5-AS1 (chromosome 6), GALTN9 (chromosome 12), FANCA (chromosome 16), and DLGAP1 (chromosome 18) (P-value < 1.0E−6). Both genomic regions near genes AADACL2 and MIR4458 remained significant following fine mapping. Conclusions: Our findings identify potential roles of regulatory miRNA, intergenic non-coding DNA, and intronic non-coding RNA in the biology of ischemic stroke. These findings reveal new molecular targets that promise to help close the current gaps in accurate African ancestry-based genetic stroke’s risk prediction and development of new targeted interventions to prevent or treat stroke

Stroke genetics informs drug discovery and risk prediction across ancestries

Previous genome-wide association studies (GWASs) of stroke - the second leading cause of death worldwide - were conducted predominantly in populations of European ancestry(1,2). Here, in cross-ancestry GWAS meta-analyses of 110,182 patients who have had a stroke (five ancestries, 33% non-European) and 1,503,898 control individuals, we identify association signals for stroke and its subtypes at 89 (61 new) independent loci: 60 in primary inverse-variance-weighted analyses and 29 in secondary meta-regression and multitrait analyses. On the basis of internal cross-ancestry validation and an independent follow-up in 89,084 additional cases of stroke (30% non-European) and 1,013,843 control individuals, 87% of the primary stroke risk loci and 60% of the secondary stroke risk loci were replicated (P < 0.05). Effect sizes were highly correlated across ancestries. Cross-ancestry fine-mapping, in silico mutagenesis analysis(3), and transcriptome-wide and proteome-wide association analyses revealed putative causal genes (such as SH3PXD2A and FURIN) and variants (such as at GRK5 and NOS3). Using a three-pronged approach(4), we provide genetic evidence for putative drug effects, highlighting F11, KLKB1, PROC, GP1BA, LAMC2 and VCAM1 as possible targets, with drugs already under investigation for stroke for F11 and PROC. A polygenic score integrating cross-ancestry and ancestry-specific stroke GWASs with vascular-risk factor GWASs (integrative polygenic scores) strongly predicted ischaemic stroke in populations of European, East Asian and African ancestry(5). Stroke genetic risk scores were predictive of ischaemic stroke independent of clinical risk factors in 52,600 clinical-trial participants with cardiometabolic disease. Our results provide insights to inform biology, reveal potential drug targets and derive genetic risk prediction tools across ancestries.</p

Stroke genetics informs drug discovery and risk prediction across ancestries

Previous genome-wide association studies (GWASs) of stroke — the second leading cause of death worldwide — were conducted predominantly in populations of European ancestry1,2. Here, in cross-ancestry GWAS meta-analyses of 110,182 patients who have had a stroke (five ancestries, 33% non-European) and 1,503,898 control individuals, we identify association signals for stroke and its subtypes at 89 (61 new) independent loci: 60 in primary inverse-variance-weighted analyses and 29 in secondary meta-regression and multitrait analyses. On the basis of internal cross-ancestry validation and an independent follow-up in 89,084 additional cases of stroke (30% non-European) and 1,013,843 control individuals, 87% of the primary stroke risk loci and 60% of the secondary stroke risk loci were replicated (P < 0.05). Effect sizes were highly correlated across ancestries. Cross-ancestry fine-mapping, in silico mutagenesis analysis3, and transcriptome-wide and proteome-wide association analyses revealed putative causal genes (such as SH3PXD2A and FURIN) and variants (such as at GRK5 and NOS3). Using a three-pronged approach4, we provide genetic evidence for putative drug effects, highlighting F11, KLKB1, PROC, GP1BA, LAMC2 and VCAM1 as possible targets, with drugs already under investigation for stroke for F11 and PROC. A polygenic score integrating cross-ancestry and ancestry-specific stroke GWASs with vascular-risk factor GWASs (integrative polygenic scores) strongly predicted ischaemic stroke in populations of European, East Asian and African ancestry5. Stroke genetic risk scores were predictive of ischaemic stroke independent of clinical risk factors in 52,600 clinical-trial participants with cardiometabolic disease. Our results provide insights to inform biology, reveal potential drug targets and derive genetic risk prediction tools across ancestries